Predictors of colectomy in patients with ulcerative colitis. A cohort analysis of 184 cases;Predictores de colectomía en enfermos con colitis ulcerativa crónica inespecífica (CUCI). Análisis de una cohorte de 184 casos

Revista de Investigacion Clinica

Volumn 56, Issue 1, 2004, Pages 11-15

  Choquet, Arsenio ^a   Yamamoto Furusho, Jesús K ^a   Reyes, Edgardo ^a   Takahashi Monroy, Takeshi ^a   Vargas Vorácková, Florencia ^a   Uscanga, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Inflammatory bowel disease; Pancolitis; Proctocolectomy; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CHI SQUARE TEST; COHORT ANALYSIS; COLON HEMORRHAGE; COLON PERFORATION; CONTROLLED STUDY; DEFECATION; FEMALE; HUMAN; HYPOALBUMINEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROCTOCOLECTOMY; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURGICAL TECHNIQUE; TACHYCARDIA; TOXIC MEGACOLON; TREATMENT FAILURE; ULCERATIVE COLITIS;

ADULT; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; PROGNOSIS;

EID: 2342424987     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28: 255-81.
2. Broström O. Prognosis in ulcerative colitis. Med Clin N Am 1990; 74: 201-18.
3. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1997; 92: 204-11.
4. Goudet P, Dozois RR, Kelly Ka, Melton LJ, Ilstrup DM, Phillips SF. Changing referral patterns for surgical treatment of ulcerative colitis. Mayo Clin Proc 1996; 71: 743-7.
5. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin N Am 1999; 28: 371-90.
6. Takahashi-Monroy T, García-Osogobio S, Mass-Panti W. Colitis ulcerativa crónica inespecifica III: tratamiento quirúrgico. En: Colon, recto y ano. Enfermedades médico-quirúrgicas. Takeshi Takahashi. (Ed). Mé xico, D.F.: Editores de Textos Médicos; 2003, 60. p. 424-31.
7. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Ruiz-Morales JA, Higuera L, Cutino T, Rodriguez-Perez JM, Villareal-Garza C, Granados J. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003; 64: 119-23.
8. Falcone RA, Lewis LG, Warner BW. Predicting the need for colectomy in pediatric patients with ulcerative colitis. J Gastrointest Surg 2000; 4: 201-6.
9. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
10. Triantafillidis JK, Emmanouilidis A, Manousus ON, Pomonis E, Tsitsa C, Cheracakis P, Barbatzas C. Ulcerative colitis in Greece: clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998; 27: 204-10.
11. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J 1955; 2: 1041-8.
12. Kim KE. Protein-losing gastroenteropathy. In: Sleisenger-Fordtran. Gastrointestinal and Liver diseases. 7th Ed. Saunders; 2002, 25, p. 446-52.
13. Anderson R, Kaariainen I, Hanauer S. Protein-losing enteropathy and massive embolism in a patient with giant inflammatory polyposis and quiescent ulcerative colitis. Am J Med 1996; 101: 323.
14. Han PD, Burke A, Baldassano RN, Rombeau JL. Lichtenstein GR. Nutrition and inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28: 423-43.
15. Michelassi F. Indications for surgical treatment in ulcerative colitis and Crohn's disease. In: Operative strategies in inflammatory bowel disease. Michelassi F, Milson JW. (Eds). Springer; 1997, p.151.
16. Powell-Tuck J, Day DW, Buckell NA, et al. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis 1982; 27: 533-7.
17. Schroeder KW. Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987; 92: 1894-98.
18. Singleton JW. Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 1987; 32: S42-S45.
19. De Dombal FT. Prognostic value of the serum protein during severe attacks of ulcerative colitis Gut 1968: 9: 144-9.
20. Marner JL, Friborg S, Simonse E. Disease activity and serum proteins in ulcerative colitis. Immunochemical quantitation. Scand J Gastroenterol 1975: 10: 537-44.
21. Buckell NA, Lennard-Jones JE, Hernandez MA, Kohn J, Riches PG, Wadsworth J. Measurements of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut 1979; 20: 22-7.
22. Cooke WT, Prior P. Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol 1984; 6: 17-25.
23. Beitia-Montes VY, Uscanga L. Las características clínicas y evolución de los enfermos con colitis ulcerativa crónica inespecífica. Tesis para obtener la especialidad de Gastroenterologia, 1999.
24. García de Acevedo B, Uscanga L. Prevalencia y factores de riesgo para cáncer de colon en pacientes con CUCI. Tesis para obtener la especialidad en Medicina Interna. 2002.
25. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003; 52: 1127-32.